Is low dose Tranexamic acid less effective than a standard dose at reducing blood loss and inhibiting hyperfibrinolysis in hemorrhagic caesarean section? Multicenter double–blind placebo-controlled dose-ranging (TRACES) trial.

Ducloy-Bouthors A, Gilliot S, Kyheng M, Faraoni D, Turbelin A, Keita H, Rigouzzo A, Moyanotidou G, Constant B, Broisin F, Le-Gouez A, Favier R, Peynaud E, Ghesquiere l, Lebuffe G, Duhamel A, Allorge D, Susen S, Hennart B, Jeanpierre E, Odou P.

Open source

DOI
10.22541/au.163584601.19864996/v1
Published
2021-11-02
Container
Not recorded
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 39/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.22541/au.163584601.19864996/v1,
  title = {Is low dose Tranexamic acid less effective than a standard dose at reducing blood loss and inhibiting hyperfibrinolysis in hemorrhagic caesarean section? Multicenter double–blind placebo-controlled dose-ranging (TRACES) trial.},
  author = {Ducloy-Bouthors A and  Gilliot S and  Kyheng M and  Faraoni D and  Turbelin A and  Keita H and  Rigouzzo A and  Moyanotidou G and  Constant B and  Broisin F and  Le-Gouez A and  Favier R and  Peynaud E and  Ghesquiere l and  Lebuffe G and  Duhamel A and  Allorge D and  Susen S and  Hennart B and  Jeanpierre E and  Odou P.},
  year = {2021},
  doi = {10.22541/au.163584601.19864996/v1},
  url = {https://doi.org/10.22541/au.163584601.19864996/v1}
}

RIS

TY  - JOUR
TI  - Is low dose Tranexamic acid less effective than a standard dose at reducing blood loss and inhibiting hyperfibrinolysis in hemorrhagic caesarean section? Multicenter double–blind placebo-controlled dose-ranging (TRACES) trial.
AU  - Ducloy-Bouthors A
AU  -  Gilliot S
AU  -  Kyheng M
AU  -  Faraoni D
AU  -  Turbelin A
AU  -  Keita H
AU  -  Rigouzzo A
AU  -  Moyanotidou G
AU  -  Constant B
AU  -  Broisin F
AU  -  Le-Gouez A
AU  -  Favier R
AU  -  Peynaud E
AU  -  Ghesquiere l
AU  -  Lebuffe G
AU  -  Duhamel A
AU  -  Allorge D
AU  -  Susen S
AU  -  Hennart B
AU  -  Jeanpierre E
AU  -  Odou P.
PY  - 2021
DO  - 10.22541/au.163584601.19864996/v1
UR  - https://doi.org/10.22541/au.163584601.19864996/v1
ER  - 

APA

A, D., S, G., M, K., D, F., A, T., H, K., A, R., G, M., B, C., F, B., A, L., R, F., E, P., l, G., G, L., A, D., D, A., S, S., B, H., E, J., & P., O. (2021). Is low dose Tranexamic acid less effective than a standard dose at reducing blood loss and inhibiting hyperfibrinolysis in hemorrhagic caesarean section? Multicenter double–blind placebo-controlled dose-ranging (TRACES) trial.. https://doi.org/10.22541/au.163584601.19864996/v1

Source records